Although Candida albicans remains the most frequent Candida species; however other species have emerged as important causes of candidiasis. In this work, we evaluated the in vitro susceptibility profile of C. albicans, C. parapsilosis, and C. tropicalis biofilms isolated from patients with candidemia to fluconazole, voriconazole, amphotericin B, and caspofungin. Differences between the biofilm ultrastructure of the three species were also determined. The isolates were phenotypically determined by growth on a Chromagar TM medium and assimilation profile on ID32C. The Scanning Electron Microscopy method (SEM) on biofilm was performed using polyurethane strips. For the in vitro susceptibility profile a microdilution in broth was used. Sessile cells were resistant to fluconazole, voriconazole and caspofungin. The resistance to amphotericin B was less pronounced and more variable between the tested isolates. In the SEM, slight differences in ultrastructural morphology for each species in biofilms were observed. Our results verified biofilm formation. Low susceptibility to the drugs in the three researched species confirmed the higher virulence of them.
INTRODUCTION
Candida species are important human pathogens because they cause high rates of morbidity and mortality in immunocompromised patients (Xie et al., 2008; Oberoi et al., 2012) . The frequency of Candida infection varies in relation to causative species. Although Candida albicans remains the most common, Candida parapsilosis, Candida tropicalis, Candida krusei, and Candida glabrata have emerged as important cause of infection (Turner & Butler, 2014) . Acquired resistance to antifungal agents has been observed amongst Candida species. Antifungal treatment can select microorganisms favoring infections caused by non-C. albicans species. Thus, continuous surveillance of species distribution trends and antifungal drug susceptibility profiles are necessary (Pfaller & Diekema, 2012) .
Virulence determinants that are selectively expressed can be involved in Candida species pathogenicity due to a host's dysfunctional defense system. Biofilm formation by Candida spp. has been implicated as a potential virulence factor in the development of candidiasis, mainly in patients using intravascular devices (Mane et al., 2012) .
Biofilms are biological communities with a high degree of organization where microorganisms form structured, coordinated and functional communities. These biological communities are embedded in extracellular polymeric substances produced by the communities themselves (Donlan, 2002) .
A biofilm has important clinical repercussions, as it is significantly less susceptible or resistant to antifungal agents (Mahmoudabadi et al., 2014). There are strong evidences that a Candida spp. biofilm is highly resistant to azoles, but there are discrepancies in the results of the effects of amphotericin B and caspofungin (Cocuaud et al., 2005; Mahmoudabadi et al., 2014) .
Morphological examination by optical and electron microscopy allows evaluation of in situ activity and of the thickness of a biofilm (Mahmoudabadi et al., 2014) . It is well known that the adsorption or neutralization of a drug could depend on the thickness of a biofilm, which presents differences among Candida species Thus, the aim of this study was to investigate the in vitro susceptibility profile of C. albicans, C. parapsilosis, and C. tropicalis biofilms isolated from patients with candidemia to fluconazole, voriconazole, amphotericin B, and caspofungin. Differences between the biofilm ultrastructure of the three species were also assessed.
MATERIAL AND METHODS
Twenty-six isolates (10 C. albicans, 10 C. parasilosis, and 6 C. tropicalis) recovered from blood from inpatients in the Intensive Care Unit (ICU) with candidemia from the "Hospital das Clínicas" of the Federal University of Goiás were examined. These previously isolated samples were stored at -70 °C in yeast extract peptone dextrose (YEPD) broth (Difco) using frozen milk.
Identification
The identification of the isolates, performed in the Mycology laboratory of Federal University of Goiás, were phenotypically determined by growth on a Chromagar TM (Chromagar company Paris, France) medium and assimilation profile on ID32C (BioMérieux France).
Antimicrobial Susceptibility Test for Plancktonic cells
Amphotericin B (Bristol-Myers Squibb, Woerden, The Netherlands), voriconazole (Pfizer Central Research, Sandwich, United Kingdom), and caspofungin (Merck & Co, Whitehouse Station, New Jersey), used in the in vitro susceptibility testing, were dissolved in dimethyl sulfoxide (DMSO) while fluconazole (Pfizer Central Research, Sandwich, United Kingdom) was dissolved in water and subsequently diluted in RPMI 1640 medium.
In vitro susceptibility tests of the cells in their free form were performed using a broth microdilution method, according to the Clinical and Laboratory Standards Institute (CLSI) document M27-S4 (CLSI, 2012). The final concentration ranged from 0.03 to 16 μg/mL for voriconazole and amphotericin B; from 0.015 to 8μg/mL for caspofungin, and from 0.125 to 64 μg/mL for fluconazole.
The minimal inhibitory concentrations (MIC) were determined visually after 24 h of incubation as the lowest drug concentration that significantly diminished growth (≥ 50%) compared to the controls for voriconazole, fluconazole, and caspofungin. For amphotericin B, complete growth inhibition was considered.
The in vitro susceptibility interpretative criteria for fluconazole, voriconazole, and caspofungin were used according to the M27-S4 (CLSI, 2012) document. The isolates were considered resistant to fluconazole with MICs ≥ 8 μg/L and to voriconazole MIC ≥ 1 μg/L. For caspofungin, MIC ≥ 1 μg/L were considered resistant for C. albicans and C. tropicalis, while for C. parapsilosis MIC ≥ 8 μg/L were considered resistant. For amphotericin B, isolates with MIC > 1 μg/L were considered resistant.
Antimicrobial Susceptibility Test for Sessile Cells
Candida isolates were cultivated on Sabouraud dextrose agar for 24 h and used to induce biofilm formation in microtiter plates at an optical density (OD) of 550 nm (Prazynska & Gospodarek, 2014) . The plates were incubated at 35°C for 48 h, washed with a 0.15 M phosphate buffer saline (PBS) to remove the planktonic cells and supplemented with fluconazole, amphotericin B, voriconazole, or caspofungin in concentrations used for sessile cells. The plates were sealed and incubated for 24 h at 37° C. After this period, the biofilm was quantified using the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) reduction assay. All antifungal agents were evaluated in concentrations 16 times higher, with the final concentrations ranging from 0.5 to 256 μg/mL for voriconazole and amphotericin B, from 0.25 to 128 μg/ mL for caspofungin, and from 2 to 1,024 μg/mL for fluconazole. Microscopic examinations of biofilms formed in microtiter plates were performed by light microscopy using an inverted microscope. The sMIC (sessile Minimun Inibition Concentration) was defined as the lowest concentration capable of reducing the absorbance by 50% (sMIC 50) and 80% (sMIC 80) compared to the control. For each isolate, in vitro biofilm susceptibility was tested in triplicate.
Scanning Electron Microscopy
The method of scanning electron microscopy (SEM) on biofilm was performed according to Bizerra et al. (2008) with some modifications. Briefly, polyurethane (PU) strips were aseptically cut and placed into 24-well cell culture plates. An inoculum (10 6 cells/mL) of Candida isolates was added to the wells of the plates containing PU strips and incubated at 35 °C for 48 h. After the incubation period, non-adherent cells were gently washed twice with PBS (0.15 M, pH 7.0). The biofilm formed was fixed with 1.25% glutaraldehyde in PBS (0.15 M, pH 7.0) for 24 h at 4°C. After fixation, the cells were dehydrated with a series of ethanol dilutions (30, 50, 70, 90, 95, and 100 %) at room temperature, subjected to the critical point of the CO 2 chamber (Autosamdri®, 815, Series A), coated with gold (Denton Vacuum Desk V.), and examined in a scanning electron microscope (JEOL, JSM -6610, equipped with EDS, Thermo scientific NSS Spectral Imaging).
RESULTS
The antifungals tested in this study showed decreased activity against sessile cells of all strains tested. The activity of amphotericin B and caspofungin was less pronounced than azole derivates and more variable between the isolates tested (Table 1) .
A range of 0.5 to 4 µg/mL for amphotericin B against C. albicans and of 0.5 to 2 µg/mL for caspofungin against C. tropicalis was found. sMIC 50 and sMIC 80 were lower for these drugs than for azole antifungals.
The data obtained in the in vitro susceptibility tests demonstrated increased values of sMIC 50 and sMIC 80 for all drugs evaluated compared to the values observed for planktonic cells as showed in Table 1 .
All species were able to form biofilms. SEM analysis of representative isolates of these species showed biofilms with clusters of ovoid yeast cells with buddings and clear constriction rings. Differences were observed between the Candida species. The organization of C. albicans biofilm was composed of a large number of hyphae and blastoconidia in a thick biofilm mass ( Figure 1A ). In the ultrastructure of C. parapsilosis, enlarged blastospores or clumps of cells were verified, but no filamentation was observed, and the biofilms were thinner ( Figure 1B) . The morphology of C. tropicalis resembled that of C. albicans, but with lower filamentation ( Figure 1C) . 
DISCUSSION
Several studies have shown that MICs of planktonic cells can be potential predictors of the clinical response to antifungals (Aller et al, 2000) . The most important feature of biofilm growth is the high resistance to antimicrobial agents that can be up to 1,000 fold greater than that of planktonic cells (Mah & OÕToole, 2001) .
Although the resistance of C. albicans in biofilm to antimycotic drugs has been well described by D'Enfert (2006) and Prazaynska & Gospodarek (2014) there is relatively little about other Candida species. Therefore, research on the susceptibility of Candida spp. biofilm remains important. In our work, biofilms of C. parapsilosis isolated from blood demonstrated high sMIC, including amphotericin B (1-128 µg/mL) and caspofungin (16->128 µg/mL). Melo et al (2011) observed resistance of C. albicans, C. tropicalis, and C. parapsilosis complex isolates to fluconazole, but, in general, verified susceptible isolates to amphotericin B, except for six (20%) C. parapsilosis strains (minimum biofilm eradication concentration -MBEC 80 ≥ 8 µg/mL). Similar to Ruzicka et al. (2007) , the biofilms of all Candida species studied in our work were resistant to the antifungal agents: amphotericin B, fluconazole, and voriconazole. Such resistance explains the persistence of many infections, A B C mainly related to the use of catheters. In our study, caspofungin was effective against the biofilm formed by C. parapsilosis, with sMIC 80 of 4 µg/mL for nine strains. However, Ziccardi et al. (2015) showed inefficacy of caspofungin against C. parapsilosis stricto sensu, and Kuhn et al. (2002) verified that this antifungal agent presented high sMIC for strains of the same species. These interstudy differences may be due to the differences in Candida biofilm models used or to the biofilm-forming abilities of Candida isolates tested (Song et al. 2005 ). Ruzicka et al. (2007) reported an increase in antifungal resistance during biofilm development, and showed that the progression of drug resistance was associated with increased metabolic activity of the developing biofilm, which indicates that drug resistance develops over time, coinciding with biofilm maturation. Therefore, growth rate is considered an important modulator of drug activity in biofilms (Mahmoudabadi et al. 2014; Prazynska & Gospodarek, 2014) .
We used SEM to visualize morphological and structural changes between the three species and verified that C. parapsilosis and C. tropicalis biofilms are not as large as those generated by C. albicans. Similar to results obtained by Junqueira et al. (2011) , C. albicans strains investigated in this study produced a large number of hyphae and blastoconidia in a thick biofilm mass. An interesting observation verified in our results was the morphology of C. tropicalis, which was similar to C. albicans, but with lower filamentation. The production of abundant blastospores without filamentation in C. parapsilosis samples observed in this study was previously reported by Lattif et al. (2010) , which suggests that other factors may be correlated to the biofilm formation besides filamentation.
The ability to form biofilms and the low susceptibility of the three species to the drugs tested confirm the high resistance of Candida and non-C. albicans species isolated from blood. Reducing the incidence of biofilm related to candidemia in hospitals is required to improve patient care, as biofilm infections have a worse prognosis.
